Search Results - "Rustenburg, F"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients by van der Pouw Kraan, T C, Wijbrandts, C A, van Baarsen, L G, Rustenburg, F, Baggen, J M, Verweij, C L, Tak, P P

    Published in Annals of the rheumatic diseases (01-04-2008)
    “…The response of rheumatoid arthritis (RA) patients to treatment with neutralising antibodies to tumour necrosis factor alpha (TNFalpha) is highly variable. The…”
    Get more information
    Journal Article
  3. 3

    Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis by van Baarsen, L G M, Wijbrandts, C A, Gerlag, D M, Rustenburg, F, van der Pouw Kraan, T C T M, Dijkmans, B A C, Tak, P P, Verweij, C L

    Published in Genes and immunity (01-12-2010)
    “…To provide insight into the pharmacological changes in the peripheral blood (PB) molecular profile induced by tumor necrosis factor (TNF)-blockade in patients…”
    Get full text
    Journal Article
  4. 4

    A subtype of multiple sclerosis defined by an activated immune defense program by van Baarsen, L G M, van der Pouw Kraan, T C T M, Kragt, J J, Baggen, J M C, Rustenburg, F, Hooper, T, Meilof, J F, Fero, M J, Dijkstra, C D, Polman, C H, Verweij, C L

    Published in Genes and immunity (01-09-2006)
    “…Given the heterogeneous nature of multiple sclerosis (MS), we applied DNA microarray technology to determine whether variability is reflected in peripheral…”
    Get full text
    Journal Article
  5. 5

    Expression of a pathogen-response program in peripheral blood cells defines a subgroup of Rheumatoid Arthritis patients by van der Pouw Kraan, T C T M, van Baarsen, L G M, Wijbrandts, C A, Voskuyl, A E, Rustenburg, F, Baggen, J M, Dijkmans, B A C, Tak, P P, Verweij, C L

    Published in Genes and immunity (01-01-2008)
    “…Rheumatoid arthritis (RA) is a heterogeneous disease with unknown etiology. Here we aimed to distinguish RA subtypes based on peripheral blood (PB) gene…”
    Get full text
    Journal Article
  6. 6

    Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers by Bos, C L, van Baarsen, L G M, Timmer, T C G, Overbeek, M J, Basoski, N M, Rustenburg, F, Baggen, J M C, Thiesen, H J, Dijkmans, B A C, van der Pouw Kraan, T C T M, Voskuyl, A E, Verweij, C L

    Published in Genes and immunity (01-04-2009)
    “…The objective of this study was to identify molecular profiles that may distinguish clinical subtypes in systemic sclerosis (SSc). Large-scale gene expression…”
    Get full text
    Journal Article
  7. 7

    Regulation of interferon response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment by van Baarsen, LGM, Wijbrandts, CA, Rustenburg, F, Cantaert, T, van der Pouw Kraan, TCTM, Baeten, D L, Dijkmans, BAC, Tak, P P, Verweij, CL

    Published in Arthritis research & therapy (01-01-2010)
    “…Introduction Cross-regulation between tumor necrosis factor (TNF) and type I interferon (IFN) has been postulated to play an important role in autoimmune…”
    Get full text
    Journal Article
  8. 8